RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Akamis Bio

Akamis Bio

Clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors.

Latest funding

$60M Series A ·

Led by Sedgwick Yard · Source: fundraisingfox.com

Funding history ↓
Website: akamisbio.com.
X: @AkamisBio · 1,000 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Oncology, Therapeutics.
Stage: Series A.
Based in: Cambridge, United States.
Founded: 2009.
Last round: Dec 17, 2024 · 699 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@AkamisBio · created Dec 3, 2010 (15 years old) · 1,000 followers
Website registeredNov 14, 2022 (4 years old)
TIMELINE · MONEY RAISED

Akamis Bio | 5128 days from X account to first raise on record

@AkamisBio·Raised $60M in 1 sourced round·2 signals before the first raise
$15M$30M$45M$60MDECJAN 2013FEBMARAPRMAYJUNJUL$60M||X ACCOUNT CREATED @AKAMISBIO · DEC 3, 2010||WEBSITE CREATED · NOV 14, 2022$60M Series A · Dec 17, 2024$60M A · DEC '24

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$60MSSedgwick Yardfundraisingfox.com

Timeline

  1. Website created
  2. X account created

Founders and team

Acquisitions

Acquired companyPriceAnnounced
HHybrid BioSystemsNot disclosed publiclyDate not given

Investors

Companies like Akamis Bio

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/akamis-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy